Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Virology. 2010 Jun 15;405(1):31–40. doi: 10.1016/j.virol.2010.05.011

Fig. 6. Anti-E7 immune responses exist only in a subset of cancer patients, whose HPV type status was known.

Fig. 6

The data document that the preferential reactivity of E7 in cancer patients does not mean that the presence of this antigen in all patients induces consistently an anti-E7 immune response.